Full name
MASTERMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
86.21.Z - General medical practice
86.22.Z - Specialist medical practice
86.23.Z - Dental practice
86.90.A - Healthcare
86.90.B - Healthcare
86.90.C - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,4 | 0,3 | 0,5 | 43,3 |
EBITDA | 0,5 | 0,5 | 0,7 | 35,8 |
Short time liabilities | 0,2 | 0,2 | 0,2 | 18 |
Equity capital | 0,7 | 1 | 1 | -4,8 |
Operating profit (EBIT) | 0,4 | 0,3 | 0,5 | 41,8 |
Assets | 1 | 1,2 | 1,2 | -3,7 |
Net profit (loss) | 0,4 | 0,3 | 0,5 | 44,5 |
Cash | 0,2 | 0,5 | 0,4 | -19,2 |
Net income from sale | 3 | 3,6 | 4,6 | 26,1 |
Liabilities and provisions for liabilities | 0,2 | 0,2 | 0,2 | 2 |
Working assets | 0,5 | 0,9 | 0,8 | -10,8 |
Depreciation | 0,1 | 0,1 | 0,2 | 21,6 |
% | % | % | p.p. | |
Profitability of capital | 58,4 | 30,2 | 45,8 | 15,6 |
Equity capital to total assets | 75,6 | 83,5 | 82,5 | -1 |
Gross profit margin | 15,1 | 9,6 | 10,9 | 1,3 |
EBITDA Margin | 17,7 | 13,4 | 14,5 | 1,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 19 | 18 | 17 | -1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane